ArticleJournal of cancer survivorship : research and practice2026
Subsequent oncology visits among cancer survivors transitioned to primary care: a retrospective cohort study.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere is increasing focus on transitioning cancer survivors from oncology to primary care, yet little is known about why some patients return to oncology following transition. We aimed to describe the reasons for and outcomes of subsequent oncology visits among cancer survivors transitioned to primary care.
methodsWe conducted a retrospective cohort study of patients transitioned to primary care at the Juravinski Cancer Centre. We analyzed all patients transitioned to primary care from 2013 to 2020. A chart review was completed for transitioned patients with subsequent oncology visits to determine the reasons for return and subsequent investigations/treatments.
resultsAmong 2604 transitioned cancer survivors, 440 (16.9%) had a subsequent oncology visit. One-third were not true re-referrals but rather visits for genetic counseling, clinical trials, or palliative care follow-up (32.7%). Apart from these, the most common reasons for visit were investigation of symptoms (32.7%) or tests (23.2%). Recurrence or new disease was detected in 28.2% of those with a subsequent visit, representing 4.8% of all transitioned patients. Most of these patients went on to receive treatment.
conclusionsOnly a small proportion of transitioned patients were referred back to oncology, and recurrence was detected in a small fraction of the overall cohort, supporting the safety of primary care led survivorship. Patients were seen for many reasons and were readily able to reconnect with oncology regardless of underlying pathology. Implications for Cancer Survivors Transitioning cancer survivors to primary care appears safe, with low recurrence rates and the ability to readily reaccess oncology care when needed.
Indexed as
Identifiers
42625094What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.